Multidose eye drop approach approved by joint commission

Multidose eye drop approach approved by joint commission

(HealthDay)—A policy and procedural approach to the use of multidose eye drops has been approved by The Joint Commission and can reduce costs for patients and facilities, according to an article published in the December issue of JAMA Ophthalmology.

Michael K. Jensen, R.Ph., from the Utah Valley Regional Medical Center in Provo, and colleagues describe the development of a policy and procedural approach to the use of multidose eye drops in a setting. They petitioned The Joint Commission for approval and assessed the cost benefits of the implementation of a multidose process for eye drop administration.

The policy and procedural approach was approved by The Joint Commission and was implemented in April 2012. The researchers found that there were significant savings for both patients and facility. There was a decrease of as much as $283.85 for patients undergoing a single cataract operation and a $330.91 decrease in costs to the facility per cataract case.

"Our policy provides a safe and effective process for administering eye drop medications to patients as well as controlling excessive to both patients and ," the authors write.


Explore further

Tear duct implant effective at reducing pain and inflammation in cataract surgery patients

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: JAMA Ophthalmology

Copyright © 2014 HealthDay. All rights reserved.

Citation: Multidose eye drop approach approved by joint commission (2014, December 14) retrieved 15 June 2021 from https://medicalxpress.com/news/2014-12-multidose-eye-approach-joint-commission.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments